nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—migraine—Acetylsalicylic acid—coronary artery disease	0.512	1	CpDpCtD
Orphenadrine—CYP2B6—Clopidogrel—coronary artery disease	0.0358	0.181	CbGbCtD
Orphenadrine—CYP2B6—Simvastatin—coronary artery disease	0.0215	0.108	CbGbCtD
Orphenadrine—SCN5A—purkinje fiber—coronary artery disease	0.0204	0.275	CbGeAlD
Orphenadrine—CYP2B6—Atorvastatin—coronary artery disease	0.0191	0.0966	CbGbCtD
Orphenadrine—CYP3A4—Ticagrelor—coronary artery disease	0.0178	0.0899	CbGbCtD
Orphenadrine—CYP3A4—Fenofibrate—coronary artery disease	0.0159	0.0802	CbGbCtD
Orphenadrine—CYP3A4—Gemfibrozil—coronary artery disease	0.0127	0.0641	CbGbCtD
Orphenadrine—KCNH2—purkinje fiber—coronary artery disease	0.0125	0.169	CbGeAlD
Orphenadrine—CYP3A4—Clopidogrel—coronary artery disease	0.011	0.0556	CbGbCtD
Orphenadrine—SCN5A—endocardium—coronary artery disease	0.0105	0.141	CbGeAlD
Orphenadrine—CYP3A4—Eplerenone—coronary artery disease	0.0102	0.0517	CbGbCtD
Orphenadrine—SCN5A—sinoatrial node—coronary artery disease	0.00996	0.134	CbGeAlD
Orphenadrine—CYP3A4—Enalapril—coronary artery disease	0.00912	0.046	CbGbCtD
Orphenadrine—CYP3A4—Ezetimibe—coronary artery disease	0.00709	0.0358	CbGbCtD
Orphenadrine—CYP3A4—Rosuvastatin—coronary artery disease	0.00709	0.0358	CbGbCtD
Orphenadrine—CYP3A4—Simvastatin—coronary artery disease	0.00659	0.0333	CbGbCtD
Orphenadrine—KCNH2—endocardium—coronary artery disease	0.00646	0.087	CbGeAlD
Orphenadrine—CYP3A4—Lovastatin—coronary artery disease	0.00645	0.0326	CbGbCtD
Orphenadrine—CYP3A4—Pravastatin—coronary artery disease	0.00645	0.0326	CbGbCtD
Orphenadrine—CYP3A4—Atorvastatin—coronary artery disease	0.00588	0.0297	CbGbCtD
Orphenadrine—CYP3A4—Losartan—coronary artery disease	0.00537	0.0271	CbGbCtD
Orphenadrine—SLC6A2—sympathetic nervous system—coronary artery disease	0.00283	0.0381	CbGeAlD
Orphenadrine—SLC6A2—autonomic nervous system—coronary artery disease	0.0019	0.0256	CbGeAlD
Orphenadrine—SCN5A—cardiac ventricle—coronary artery disease	0.000884	0.0119	CbGeAlD
Orphenadrine—SCN5A—myocardium—coronary artery disease	0.000832	0.0112	CbGeAlD
Orphenadrine—SCN4A—heart—coronary artery disease	0.000749	0.0101	CbGeAlD
Orphenadrine—Cyclizine—SULT1E1—coronary artery disease	0.000641	0.146	CrCbGaD
Orphenadrine—SCN5A—heart—coronary artery disease	0.000581	0.00781	CbGeAlD
Orphenadrine—SCN5A—cardiovascular system—coronary artery disease	0.000548	0.00737	CbGeAlD
Orphenadrine—KCNH2—cardiac ventricle—coronary artery disease	0.000544	0.00732	CbGeAlD
Orphenadrine—Phenprocoumon—VKORC1—coronary artery disease	0.000529	0.121	CrCbGaD
Orphenadrine—KCNH2—myocardium—coronary artery disease	0.000511	0.00688	CbGeAlD
Orphenadrine—SCN5A—cardiac atrium—coronary artery disease	0.000497	0.00668	CbGeAlD
Orphenadrine—CHRM2—heart—coronary artery disease	0.000494	0.00665	CbGeAlD
Orphenadrine—SCN10A—blood—coronary artery disease	0.000477	0.00642	CbGeAlD
Orphenadrine—Warfarin—VKORC1—coronary artery disease	0.000469	0.107	CrCbGaD
Orphenadrine—CHRM2—cardiovascular system—coronary artery disease	0.000466	0.00628	CbGeAlD
Orphenadrine—SCN5A—blood—coronary artery disease	0.000433	0.00583	CbGeAlD
Orphenadrine—KCNH2—heart—coronary artery disease	0.000357	0.00481	CbGeAlD
Orphenadrine—KCNH2—cardiovascular system—coronary artery disease	0.000337	0.00453	CbGeAlD
Orphenadrine—KCNH2—cardiac atrium—coronary artery disease	0.000305	0.00411	CbGeAlD
Orphenadrine—CYP2B6—heart—coronary artery disease	0.000293	0.00394	CbGeAlD
Orphenadrine—CYP2B6—cardiovascular system—coronary artery disease	0.000276	0.00372	CbGeAlD
Orphenadrine—Constipation—Eplerenone—coronary artery disease	0.000267	0.00226	CcSEcCtD
Orphenadrine—Tremor—Losartan—coronary artery disease	0.000267	0.00226	CcSEcCtD
Orphenadrine—KCNH2—blood—coronary artery disease	0.000266	0.00359	CbGeAlD
Orphenadrine—Anaphylactic shock—Enalapril—coronary artery disease	0.000266	0.00225	CcSEcCtD
Orphenadrine—Urticaria—Fenofibrate—coronary artery disease	0.000265	0.00224	CcSEcCtD
Orphenadrine—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000264	0.00224	CcSEcCtD
Orphenadrine—Feeling abnormal—Ezetimibe—coronary artery disease	0.000263	0.00223	CcSEcCtD
Orphenadrine—Anaphylactic shock—Telmisartan—coronary artery disease	0.000262	0.00222	CcSEcCtD
Orphenadrine—Agitation—Losartan—coronary artery disease	0.000262	0.00222	CcSEcCtD
Orphenadrine—Tachycardia—Trandolapril—coronary artery disease	0.000261	0.00221	CcSEcCtD
Orphenadrine—Constipation—Simvastatin—coronary artery disease	0.00026	0.0022	CcSEcCtD
Orphenadrine—Urticaria—Clopidogrel—coronary artery disease	0.00026	0.0022	CcSEcCtD
Orphenadrine—Tamoxifen—SULT1A1—coronary artery disease	0.00026	0.0594	CrCbGaD
Orphenadrine—Tachycardia—Enalapril—coronary artery disease	0.00026	0.0022	CcSEcCtD
Orphenadrine—CYP2E1—cardiovascular system—coronary artery disease	0.000259	0.00349	CbGeAlD
Orphenadrine—Skin disorder—Trandolapril—coronary artery disease	0.000259	0.0022	CcSEcCtD
Orphenadrine—Nausea—Gemfibrozil—coronary artery disease	0.000259	0.0022	CcSEcCtD
Orphenadrine—Urticaria—Lovastatin—coronary artery disease	0.000258	0.00219	CcSEcCtD
Orphenadrine—Feeling abnormal—Eplerenone—coronary artery disease	0.000257	0.00218	CcSEcCtD
Orphenadrine—Confusional state—Captopril—coronary artery disease	0.000257	0.00218	CcSEcCtD
Orphenadrine—Tachycardia—Telmisartan—coronary artery disease	0.000256	0.00217	CcSEcCtD
Orphenadrine—Somnolence—Valsartan—coronary artery disease	0.000255	0.00216	CcSEcCtD
Orphenadrine—Anaphylactic shock—Captopril—coronary artery disease	0.000255	0.00216	CcSEcCtD
Orphenadrine—Skin disorder—Telmisartan—coronary artery disease	0.000255	0.00216	CcSEcCtD
Orphenadrine—Dizziness—Rosuvastatin—coronary artery disease	0.000254	0.00215	CcSEcCtD
Orphenadrine—Urticaria—Ezetimibe—coronary artery disease	0.000253	0.00215	CcSEcCtD
Orphenadrine—Nausea—Ticagrelor—coronary artery disease	0.000253	0.00215	CcSEcCtD
Orphenadrine—Hallucination—Lisinopril—coronary artery disease	0.000253	0.00214	CcSEcCtD
Orphenadrine—Palpitations—Losartan—coronary artery disease	0.000251	0.00213	CcSEcCtD
Orphenadrine—Feeling abnormal—Simvastatin—coronary artery disease	0.000251	0.00212	CcSEcCtD
Orphenadrine—Confusional state—Perindopril—coronary artery disease	0.00025	0.00212	CcSEcCtD
Orphenadrine—Tachycardia—Captopril—coronary artery disease	0.000249	0.00211	CcSEcCtD
Orphenadrine—Somnolence—Niacin—coronary artery disease	0.000248	0.0021	CcSEcCtD
Orphenadrine—Anaphylactic shock—Perindopril—coronary artery disease	0.000248	0.0021	CcSEcCtD
Orphenadrine—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000246	0.00209	CcSEcCtD
Orphenadrine—Constipation—Valsartan—coronary artery disease	0.000246	0.00208	CcSEcCtD
Orphenadrine—Hypersensitivity—Fenofibrate—coronary artery disease	0.000245	0.00208	CcSEcCtD
Orphenadrine—Constipation—Olmesartan—coronary artery disease	0.000244	0.00207	CcSEcCtD
Orphenadrine—Confusional state—Furosemide—coronary artery disease	0.000243	0.00206	CcSEcCtD
Orphenadrine—Tachycardia—Perindopril—coronary artery disease	0.000242	0.00205	CcSEcCtD
Orphenadrine—Urticaria—Simvastatin—coronary artery disease	0.000242	0.00205	CcSEcCtD
Orphenadrine—Hypersensitivity—Clopidogrel—coronary artery disease	0.000241	0.00204	CcSEcCtD
Orphenadrine—Anaphylactic shock—Furosemide—coronary artery disease	0.000241	0.00204	CcSEcCtD
Orphenadrine—Skin disorder—Perindopril—coronary artery disease	0.000241	0.00204	CcSEcCtD
Orphenadrine—Headache—Rosuvastatin—coronary artery disease	0.00024	0.00204	CcSEcCtD
Orphenadrine—Hypersensitivity—Lovastatin—coronary artery disease	0.00024	0.00203	CcSEcCtD
Orphenadrine—Tension—Ramipril—coronary artery disease	0.000239	0.00203	CcSEcCtD
Orphenadrine—Asthenia—Fenofibrate—coronary artery disease	0.000239	0.00203	CcSEcCtD
Orphenadrine—Somnolence—Trandolapril—coronary artery disease	0.000237	0.00201	CcSEcCtD
Orphenadrine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000237	0.00201	CcSEcCtD
Orphenadrine—Somnolence—Enalapril—coronary artery disease	0.000236	0.002	CcSEcCtD
Orphenadrine—Pruritus—Fenofibrate—coronary artery disease	0.000236	0.002	CcSEcCtD
Orphenadrine—Feeling abnormal—Olmesartan—coronary artery disease	0.000236	0.002	CcSEcCtD
Orphenadrine—Constipation—Pravastatin—coronary artery disease	0.000235	0.00199	CcSEcCtD
Orphenadrine—Hypersensitivity—Ezetimibe—coronary artery disease	0.000235	0.00199	CcSEcCtD
Orphenadrine—Asthenia—Clopidogrel—coronary artery disease	0.000235	0.00199	CcSEcCtD
Orphenadrine—Confusional state—Losartan—coronary artery disease	0.000234	0.00199	CcSEcCtD
Orphenadrine—Tension—Timolol—coronary artery disease	0.000234	0.00198	CcSEcCtD
Orphenadrine—Skin disorder—Furosemide—coronary artery disease	0.000234	0.00198	CcSEcCtD
Orphenadrine—Asthenia—Lovastatin—coronary artery disease	0.000233	0.00198	CcSEcCtD
Orphenadrine—Somnolence—Telmisartan—coronary artery disease	0.000233	0.00198	CcSEcCtD
Orphenadrine—Anaphylactic shock—Losartan—coronary artery disease	0.000232	0.00197	CcSEcCtD
Orphenadrine—Pruritus—Clopidogrel—coronary artery disease	0.000232	0.00196	CcSEcCtD
Orphenadrine—Pruritus—Lovastatin—coronary artery disease	0.00023	0.00195	CcSEcCtD
Orphenadrine—Asthenia—Ezetimibe—coronary artery disease	0.000229	0.00194	CcSEcCtD
Orphenadrine—Tremor—Ramipril—coronary artery disease	0.000229	0.00194	CcSEcCtD
Orphenadrine—Constipation—Trandolapril—coronary artery disease	0.000228	0.00194	CcSEcCtD
Orphenadrine—Urticaria—Valsartan—coronary artery disease	0.000228	0.00193	CcSEcCtD
Orphenadrine—Nausea—Rosuvastatin—coronary artery disease	0.000228	0.00193	CcSEcCtD
Orphenadrine—Constipation—Enalapril—coronary artery disease	0.000227	0.00193	CcSEcCtD
Orphenadrine—Urticaria—Olmesartan—coronary artery disease	0.000227	0.00193	CcSEcCtD
Orphenadrine—Somnolence—Captopril—coronary artery disease	0.000227	0.00192	CcSEcCtD
Orphenadrine—Tachycardia—Losartan—coronary artery disease	0.000227	0.00192	CcSEcCtD
Orphenadrine—Feeling abnormal—Pravastatin—coronary artery disease	0.000227	0.00192	CcSEcCtD
Orphenadrine—Pruritus—Ezetimibe—coronary artery disease	0.000226	0.00191	CcSEcCtD
Orphenadrine—Vision blurred—Timolol—coronary artery disease	0.000225	0.00191	CcSEcCtD
Orphenadrine—Constipation—Telmisartan—coronary artery disease	0.000224	0.0019	CcSEcCtD
Orphenadrine—Agitation—Ramipril—coronary artery disease	0.000224	0.0019	CcSEcCtD
Orphenadrine—Hypersensitivity—Simvastatin—coronary artery disease	0.000224	0.0019	CcSEcCtD
Orphenadrine—Asthenia—Eplerenone—coronary artery disease	0.000224	0.0019	CcSEcCtD
Orphenadrine—Urticaria—Niacin—coronary artery disease	0.000222	0.00188	CcSEcCtD
Orphenadrine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000221	0.00188	CcSEcCtD
Orphenadrine—Pruritus—Eplerenone—coronary artery disease	0.000221	0.00187	CcSEcCtD
Orphenadrine—Dizziness—Fenofibrate—coronary artery disease	0.00022	0.00187	CcSEcCtD
Orphenadrine—Somnolence—Perindopril—coronary artery disease	0.00022	0.00187	CcSEcCtD
Orphenadrine—Feeling abnormal—Trandolapril—coronary artery disease	0.00022	0.00187	CcSEcCtD
Orphenadrine—Feeling abnormal—Enalapril—coronary artery disease	0.000219	0.00186	CcSEcCtD
Orphenadrine—CYP2B6—blood—coronary artery disease	0.000219	0.00294	CbGeAlD
Orphenadrine—Urticaria—Pravastatin—coronary artery disease	0.000218	0.00185	CcSEcCtD
Orphenadrine—Asthenia—Simvastatin—coronary artery disease	0.000218	0.00185	CcSEcCtD
Orphenadrine—Constipation—Captopril—coronary artery disease	0.000218	0.00185	CcSEcCtD
Orphenadrine—Tension—Lisinopril—coronary artery disease	0.000217	0.00184	CcSEcCtD
Orphenadrine—Dizziness—Clopidogrel—coronary artery disease	0.000216	0.00184	CcSEcCtD
Orphenadrine—Feeling abnormal—Telmisartan—coronary artery disease	0.000216	0.00183	CcSEcCtD
Orphenadrine—Palpitations—Ramipril—coronary artery disease	0.000216	0.00183	CcSEcCtD
Orphenadrine—Pruritus—Simvastatin—coronary artery disease	0.000215	0.00182	CcSEcCtD
Orphenadrine—Dizziness—Lovastatin—coronary artery disease	0.000215	0.00182	CcSEcCtD
Orphenadrine—Somnolence—Furosemide—coronary artery disease	0.000214	0.00181	CcSEcCtD
Orphenadrine—Urticaria—Trandolapril—coronary artery disease	0.000212	0.0018	CcSEcCtD
Orphenadrine—Constipation—Perindopril—coronary artery disease	0.000212	0.0018	CcSEcCtD
Orphenadrine—Vomiting—Fenofibrate—coronary artery disease	0.000212	0.00179	CcSEcCtD
Orphenadrine—Hypersensitivity—Valsartan—coronary artery disease	0.000212	0.00179	CcSEcCtD
Orphenadrine—Urticaria—Enalapril—coronary artery disease	0.000211	0.00179	CcSEcCtD
Orphenadrine—Dizziness—Ezetimibe—coronary artery disease	0.000211	0.00179	CcSEcCtD
Orphenadrine—Palpitations—Timolol—coronary artery disease	0.000211	0.00179	CcSEcCtD
Orphenadrine—Feeling abnormal—Captopril—coronary artery disease	0.00021	0.00178	CcSEcCtD
Orphenadrine—Headache—Fenofibrate—coronary artery disease	0.000209	0.00177	CcSEcCtD
Orphenadrine—Vision blurred—Lisinopril—coronary artery disease	0.000209	0.00177	CcSEcCtD
Orphenadrine—Urticaria—Telmisartan—coronary artery disease	0.000208	0.00177	CcSEcCtD
Orphenadrine—Vomiting—Clopidogrel—coronary artery disease	0.000208	0.00176	CcSEcCtD
Orphenadrine—Tremor—Lisinopril—coronary artery disease	0.000207	0.00176	CcSEcCtD
Orphenadrine—Vomiting—Lovastatin—coronary artery disease	0.000207	0.00175	CcSEcCtD
Orphenadrine—Somnolence—Losartan—coronary artery disease	0.000206	0.00175	CcSEcCtD
Orphenadrine—Dizziness—Eplerenone—coronary artery disease	0.000206	0.00175	CcSEcCtD
Orphenadrine—Asthenia—Valsartan—coronary artery disease	0.000206	0.00175	CcSEcCtD
Orphenadrine—Constipation—Furosemide—coronary artery disease	0.000206	0.00175	CcSEcCtD
Orphenadrine—Hypersensitivity—Niacin—coronary artery disease	0.000206	0.00174	CcSEcCtD
Orphenadrine—CYP2E1—blood—coronary artery disease	0.000205	0.00276	CbGeAlD
Orphenadrine—Asthenia—Olmesartan—coronary artery disease	0.000205	0.00174	CcSEcCtD
Orphenadrine—Headache—Clopidogrel—coronary artery disease	0.000205	0.00174	CcSEcCtD
Orphenadrine—Feeling abnormal—Perindopril—coronary artery disease	0.000204	0.00173	CcSEcCtD
Orphenadrine—Headache—Lovastatin—coronary artery disease	0.000204	0.00173	CcSEcCtD
Orphenadrine—Pruritus—Valsartan—coronary artery disease	0.000203	0.00172	CcSEcCtD
Orphenadrine—Vomiting—Ezetimibe—coronary artery disease	0.000203	0.00172	CcSEcCtD
Orphenadrine—Hypersensitivity—Pravastatin—coronary artery disease	0.000203	0.00172	CcSEcCtD
Orphenadrine—Pruritus—Olmesartan—coronary artery disease	0.000202	0.00171	CcSEcCtD
Orphenadrine—Dizziness—Simvastatin—coronary artery disease	0.000201	0.00171	CcSEcCtD
Orphenadrine—Confusional state—Ramipril—coronary artery disease	0.000201	0.0017	CcSEcCtD
Orphenadrine—Asthenia—Niacin—coronary artery disease	0.0002	0.0017	CcSEcCtD
Orphenadrine—Headache—Ezetimibe—coronary artery disease	0.0002	0.00169	CcSEcCtD
Orphenadrine—Anaphylactic shock—Ramipril—coronary artery disease	0.000199	0.00169	CcSEcCtD
Orphenadrine—Constipation—Losartan—coronary artery disease	0.000199	0.00168	CcSEcCtD
Orphenadrine—Vomiting—Eplerenone—coronary artery disease	0.000198	0.00168	CcSEcCtD
Orphenadrine—Feeling abnormal—Furosemide—coronary artery disease	0.000198	0.00168	CcSEcCtD
Orphenadrine—Nausea—Fenofibrate—coronary artery disease	0.000198	0.00168	CcSEcCtD
Orphenadrine—Pruritus—Niacin—coronary artery disease	0.000198	0.00168	CcSEcCtD
Orphenadrine—Asthenia—Pravastatin—coronary artery disease	0.000197	0.00167	CcSEcCtD
Orphenadrine—Urticaria—Perindopril—coronary artery disease	0.000197	0.00167	CcSEcCtD
Orphenadrine—Hypersensitivity—Trandolapril—coronary artery disease	0.000197	0.00167	CcSEcCtD
Orphenadrine—Confusional state—Timolol—coronary artery disease	0.000196	0.00166	CcSEcCtD
Orphenadrine—Hypersensitivity—Enalapril—coronary artery disease	0.000196	0.00166	CcSEcCtD
Orphenadrine—Palpitations—Lisinopril—coronary artery disease	0.000196	0.00166	CcSEcCtD
Orphenadrine—Headache—Eplerenone—coronary artery disease	0.000196	0.00166	CcSEcCtD
Orphenadrine—Anaphylactic shock—Timolol—coronary artery disease	0.000195	0.00165	CcSEcCtD
Orphenadrine—Pruritus—Pravastatin—coronary artery disease	0.000195	0.00165	CcSEcCtD
Orphenadrine—Nausea—Clopidogrel—coronary artery disease	0.000194	0.00165	CcSEcCtD
Orphenadrine—Tachycardia—Ramipril—coronary artery disease	0.000194	0.00165	CcSEcCtD
Orphenadrine—Skin disorder—Ramipril—coronary artery disease	0.000193	0.00164	CcSEcCtD
Orphenadrine—Vomiting—Simvastatin—coronary artery disease	0.000193	0.00164	CcSEcCtD
Orphenadrine—Hypersensitivity—Telmisartan—coronary artery disease	0.000193	0.00164	CcSEcCtD
Orphenadrine—Nausea—Lovastatin—coronary artery disease	0.000193	0.00164	CcSEcCtD
Orphenadrine—Asthenia—Trandolapril—coronary artery disease	0.000192	0.00162	CcSEcCtD
Orphenadrine—Feeling abnormal—Losartan—coronary artery disease	0.000191	0.00162	CcSEcCtD
Orphenadrine—Urticaria—Furosemide—coronary artery disease	0.000191	0.00162	CcSEcCtD
Orphenadrine—Asthenia—Enalapril—coronary artery disease	0.000191	0.00162	CcSEcCtD
Orphenadrine—Headache—Simvastatin—coronary artery disease	0.000191	0.00162	CcSEcCtD
Orphenadrine—Dizziness—Valsartan—coronary artery disease	0.00019	0.00161	CcSEcCtD
Orphenadrine—Nausea—Ezetimibe—coronary artery disease	0.000189	0.00161	CcSEcCtD
Orphenadrine—Skin disorder—Timolol—coronary artery disease	0.000189	0.0016	CcSEcCtD
Orphenadrine—Dizziness—Olmesartan—coronary artery disease	0.000189	0.0016	CcSEcCtD
Orphenadrine—Pruritus—Trandolapril—coronary artery disease	0.000189	0.0016	CcSEcCtD
Orphenadrine—Asthenia—Telmisartan—coronary artery disease	0.000188	0.0016	CcSEcCtD
Orphenadrine—Pruritus—Enalapril—coronary artery disease	0.000188	0.0016	CcSEcCtD
Orphenadrine—Pruritus—Telmisartan—coronary artery disease	0.000186	0.00157	CcSEcCtD
Orphenadrine—Nausea—Eplerenone—coronary artery disease	0.000185	0.00157	CcSEcCtD
Orphenadrine—Dizziness—Niacin—coronary artery disease	0.000185	0.00157	CcSEcCtD
Orphenadrine—Urticaria—Losartan—coronary artery disease	0.000185	0.00156	CcSEcCtD
Orphenadrine—Asthenia—Captopril—coronary artery disease	0.000183	0.00155	CcSEcCtD
Orphenadrine—Vomiting—Valsartan—coronary artery disease	0.000183	0.00155	CcSEcCtD
Orphenadrine—Confusional state—Lisinopril—coronary artery disease	0.000182	0.00154	CcSEcCtD
Orphenadrine—Dizziness—Pravastatin—coronary artery disease	0.000182	0.00154	CcSEcCtD
Orphenadrine—Vomiting—Olmesartan—coronary artery disease	0.000182	0.00154	CcSEcCtD
Orphenadrine—Nausea—Simvastatin—coronary artery disease	0.000181	0.00153	CcSEcCtD
Orphenadrine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000181	0.00153	CcSEcCtD
Orphenadrine—Pruritus—Captopril—coronary artery disease	0.00018	0.00153	CcSEcCtD
Orphenadrine—Headache—Valsartan—coronary artery disease	0.00018	0.00153	CcSEcCtD
Orphenadrine—Headache—Olmesartan—coronary artery disease	0.000179	0.00152	CcSEcCtD
Orphenadrine—Asthenia—Perindopril—coronary artery disease	0.000178	0.00151	CcSEcCtD
Orphenadrine—Vomiting—Niacin—coronary artery disease	0.000178	0.00151	CcSEcCtD
Orphenadrine—Hypersensitivity—Furosemide—coronary artery disease	0.000177	0.0015	CcSEcCtD
Orphenadrine—Somnolence—Ramipril—coronary artery disease	0.000177	0.0015	CcSEcCtD
Orphenadrine—Dizziness—Trandolapril—coronary artery disease	0.000177	0.0015	CcSEcCtD
Orphenadrine—Tachycardia—Lisinopril—coronary artery disease	0.000176	0.00149	CcSEcCtD
Orphenadrine—Dizziness—Enalapril—coronary artery disease	0.000176	0.00149	CcSEcCtD
Orphenadrine—Skin disorder—Lisinopril—coronary artery disease	0.000175	0.00149	CcSEcCtD
Orphenadrine—Pruritus—Perindopril—coronary artery disease	0.000175	0.00149	CcSEcCtD
Orphenadrine—Headache—Niacin—coronary artery disease	0.000175	0.00148	CcSEcCtD
Orphenadrine—Vomiting—Pravastatin—coronary artery disease	0.000175	0.00148	CcSEcCtD
Orphenadrine—Dizziness—Telmisartan—coronary artery disease	0.000173	0.00147	CcSEcCtD
Orphenadrine—Somnolence—Timolol—coronary artery disease	0.000173	0.00147	CcSEcCtD
Orphenadrine—Asthenia—Furosemide—coronary artery disease	0.000173	0.00146	CcSEcCtD
Orphenadrine—Headache—Pravastatin—coronary artery disease	0.000172	0.00146	CcSEcCtD
Orphenadrine—Hypersensitivity—Losartan—coronary artery disease	0.000171	0.00145	CcSEcCtD
Orphenadrine—Doxepin—HRH2—coronary artery disease	0.000171	0.039	CrCbGaD
Orphenadrine—Nausea—Valsartan—coronary artery disease	0.000171	0.00145	CcSEcCtD
Orphenadrine—Pruritus—Furosemide—coronary artery disease	0.00017	0.00144	CcSEcCtD
Orphenadrine—Constipation—Ramipril—coronary artery disease	0.00017	0.00144	CcSEcCtD
Orphenadrine—Nausea—Olmesartan—coronary artery disease	0.00017	0.00144	CcSEcCtD
Orphenadrine—Vomiting—Trandolapril—coronary artery disease	0.00017	0.00144	CcSEcCtD
Orphenadrine—Vomiting—Enalapril—coronary artery disease	0.000169	0.00143	CcSEcCtD
Orphenadrine—Dizziness—Captopril—coronary artery disease	0.000169	0.00143	CcSEcCtD
Orphenadrine—Headache—Trandolapril—coronary artery disease	0.000167	0.00142	CcSEcCtD
Orphenadrine—Vomiting—Telmisartan—coronary artery disease	0.000167	0.00141	CcSEcCtD
Orphenadrine—Asthenia—Losartan—coronary artery disease	0.000167	0.00141	CcSEcCtD
Orphenadrine—Headache—Enalapril—coronary artery disease	0.000167	0.00141	CcSEcCtD
Orphenadrine—Nausea—Niacin—coronary artery disease	0.000166	0.00141	CcSEcCtD
Orphenadrine—CYP3A4—blood—coronary artery disease	0.000165	0.00222	CbGeAlD
Orphenadrine—Pruritus—Losartan—coronary artery disease	0.000164	0.00139	CcSEcCtD
Orphenadrine—Headache—Telmisartan—coronary artery disease	0.000164	0.00139	CcSEcCtD
Orphenadrine—Feeling abnormal—Ramipril—coronary artery disease	0.000164	0.00139	CcSEcCtD
Orphenadrine—Dizziness—Perindopril—coronary artery disease	0.000164	0.00139	CcSEcCtD
Orphenadrine—Nausea—Pravastatin—coronary artery disease	0.000163	0.00138	CcSEcCtD
Orphenadrine—Vomiting—Captopril—coronary artery disease	0.000162	0.00137	CcSEcCtD
Orphenadrine—Somnolence—Lisinopril—coronary artery disease	0.000161	0.00136	CcSEcCtD
Orphenadrine—Feeling abnormal—Timolol—coronary artery disease	0.00016	0.00136	CcSEcCtD
Orphenadrine—Headache—Captopril—coronary artery disease	0.00016	0.00135	CcSEcCtD
Orphenadrine—Dizziness—Furosemide—coronary artery disease	0.000159	0.00135	CcSEcCtD
Orphenadrine—Nausea—Trandolapril—coronary artery disease	0.000159	0.00134	CcSEcCtD
Orphenadrine—Urticaria—Ramipril—coronary artery disease	0.000158	0.00134	CcSEcCtD
Orphenadrine—Nausea—Enalapril—coronary artery disease	0.000158	0.00134	CcSEcCtD
Orphenadrine—Vomiting—Perindopril—coronary artery disease	0.000157	0.00133	CcSEcCtD
Orphenadrine—Nausea—Telmisartan—coronary artery disease	0.000156	0.00132	CcSEcCtD
Orphenadrine—Headache—Perindopril—coronary artery disease	0.000155	0.00132	CcSEcCtD
Orphenadrine—Urticaria—Timolol—coronary artery disease	0.000155	0.00131	CcSEcCtD
Orphenadrine—Constipation—Lisinopril—coronary artery disease	0.000154	0.00131	CcSEcCtD
Orphenadrine—Dizziness—Losartan—coronary artery disease	0.000154	0.0013	CcSEcCtD
Orphenadrine—Vomiting—Furosemide—coronary artery disease	0.000153	0.0013	CcSEcCtD
Orphenadrine—Nausea—Captopril—coronary artery disease	0.000151	0.00128	CcSEcCtD
Orphenadrine—Headache—Furosemide—coronary artery disease	0.000151	0.00128	CcSEcCtD
Orphenadrine—Feeling abnormal—Lisinopril—coronary artery disease	0.000149	0.00126	CcSEcCtD
Orphenadrine—Vomiting—Losartan—coronary artery disease	0.000148	0.00125	CcSEcCtD
Orphenadrine—Nausea—Perindopril—coronary artery disease	0.000147	0.00125	CcSEcCtD
Orphenadrine—Hypersensitivity—Ramipril—coronary artery disease	0.000147	0.00124	CcSEcCtD
Orphenadrine—Headache—Losartan—coronary artery disease	0.000146	0.00123	CcSEcCtD
Orphenadrine—Urticaria—Lisinopril—coronary artery disease	0.000143	0.00122	CcSEcCtD
Orphenadrine—Hypersensitivity—Timolol—coronary artery disease	0.000143	0.00122	CcSEcCtD
Orphenadrine—Nausea—Furosemide—coronary artery disease	0.000143	0.00121	CcSEcCtD
Orphenadrine—Asthenia—Ramipril—coronary artery disease	0.000143	0.00121	CcSEcCtD
Orphenadrine—Pruritus—Ramipril—coronary artery disease	0.000141	0.00119	CcSEcCtD
Orphenadrine—Asthenia—Timolol—coronary artery disease	0.00014	0.00118	CcSEcCtD
Orphenadrine—Nausea—Losartan—coronary artery disease	0.000138	0.00117	CcSEcCtD
Orphenadrine—Pruritus—Timolol—coronary artery disease	0.000138	0.00117	CcSEcCtD
Orphenadrine—Hypersensitivity—Lisinopril—coronary artery disease	0.000133	0.00113	CcSEcCtD
Orphenadrine—Dextropropoxyphene—OPRD1—coronary artery disease	0.000132	0.0302	CrCbGaD
Orphenadrine—Amitriptyline—HRH2—coronary artery disease	0.000132	0.0302	CrCbGaD
Orphenadrine—Dizziness—Ramipril—coronary artery disease	0.000132	0.00112	CcSEcCtD
Orphenadrine—Asthenia—Lisinopril—coronary artery disease	0.00013	0.0011	CcSEcCtD
Orphenadrine—Dizziness—Timolol—coronary artery disease	0.000129	0.00109	CcSEcCtD
Orphenadrine—Pruritus—Lisinopril—coronary artery disease	0.000128	0.00108	CcSEcCtD
Orphenadrine—Vomiting—Ramipril—coronary artery disease	0.000127	0.00107	CcSEcCtD
Orphenadrine—Headache—Ramipril—coronary artery disease	0.000125	0.00106	CcSEcCtD
Orphenadrine—Vomiting—Timolol—coronary artery disease	0.000124	0.00105	CcSEcCtD
Orphenadrine—Headache—Timolol—coronary artery disease	0.000122	0.00103	CcSEcCtD
Orphenadrine—Dizziness—Lisinopril—coronary artery disease	0.000119	0.00101	CcSEcCtD
Orphenadrine—Nausea—Ramipril—coronary artery disease	0.000118	0.001	CcSEcCtD
Orphenadrine—Nausea—Timolol—coronary artery disease	0.000116	0.000981	CcSEcCtD
Orphenadrine—Vomiting—Lisinopril—coronary artery disease	0.000115	0.000974	CcSEcCtD
Orphenadrine—Headache—Lisinopril—coronary artery disease	0.000113	0.000959	CcSEcCtD
Orphenadrine—Toremifene—ESR1—coronary artery disease	0.000113	0.0258	CrCbGaD
Orphenadrine—Phenoxybenzamine—SLC22A3—coronary artery disease	0.000112	0.0257	CrCbGaD
Orphenadrine—Nausea—Lisinopril—coronary artery disease	0.000107	0.00091	CcSEcCtD
Orphenadrine—Methadone—OPRD1—coronary artery disease	8.97e-05	0.0205	CrCbGaD
Orphenadrine—Tolterodine—CYP2C19—coronary artery disease	7.5e-05	0.0171	CrCbGaD
Orphenadrine—Tamoxifen—ESR2—coronary artery disease	7.31e-05	0.0167	CrCbGaD
Orphenadrine—Benzatropine—CYP2C19—coronary artery disease	7.22e-05	0.0165	CrCbGaD
Orphenadrine—Fluoxetine—CYP2C19—coronary artery disease	7.15e-05	0.0163	CrCbGaD
Orphenadrine—Imipramine—SLC22A3—coronary artery disease	7.12e-05	0.0163	CrCbGaD
Orphenadrine—Amitriptyline—OPRD1—coronary artery disease	6.97e-05	0.0159	CrCbGaD
Orphenadrine—Warfarin—CYP2C19—coronary artery disease	6.52e-05	0.0149	CrCbGaD
Orphenadrine—Carbinoxamine—CYP2C19—coronary artery disease	6.43e-05	0.0147	CrCbGaD
Orphenadrine—Cyclobenzaprine—HTR2A—coronary artery disease	6.34e-05	0.0145	CrCbGaD
Orphenadrine—Fluoxetine—HTR2A—coronary artery disease	5.8e-05	0.0133	CrCbGaD
Orphenadrine—Brompheniramine—CYP2C19—coronary artery disease	5.57e-05	0.0127	CrCbGaD
Orphenadrine—Modafinil—CYP2C19—coronary artery disease	5.34e-05	0.0122	CrCbGaD
Orphenadrine—Fenoprofen—PTGS2—coronary artery disease	5.31e-05	0.0121	CrCbGaD
Orphenadrine—Phenoxybenzamine—ADRB2—coronary artery disease	5.14e-05	0.0118	CrCbGaD
Orphenadrine—Fenoprofen—ALB—coronary artery disease	4.73e-05	0.0108	CrCbGaD
Orphenadrine—Atomoxetine—CYP2C19—coronary artery disease	4.6e-05	0.0105	CrCbGaD
Orphenadrine—Imipramine—HTR7—coronary artery disease	4.52e-05	0.0103	CrCbGaD
Orphenadrine—Tamoxifen—ESR1—coronary artery disease	4.5e-05	0.0103	CrCbGaD
Orphenadrine—Amitriptyline—HTR7—coronary artery disease	4.49e-05	0.0103	CrCbGaD
Orphenadrine—Phenprocoumon—ALB—coronary artery disease	4.08e-05	0.00932	CrCbGaD
Orphenadrine—Fluoxetine—ALB—coronary artery disease	3.97e-05	0.00907	CrCbGaD
Orphenadrine—Trimipramine—CYP2C19—coronary artery disease	3.78e-05	0.00864	CrCbGaD
Orphenadrine—Atomoxetine—HTR2A—coronary artery disease	3.73e-05	0.00852	CrCbGaD
Orphenadrine—Diphenhydramine—CYP2C19—coronary artery disease	3.71e-05	0.00848	CrCbGaD
Orphenadrine—Warfarin—ALB—coronary artery disease	3.62e-05	0.00827	CrCbGaD
Orphenadrine—Tamoxifen—CYP2C19—coronary artery disease	3.61e-05	0.00826	CrCbGaD
Orphenadrine—Doxepin—CYP2C19—coronary artery disease	3.6e-05	0.00823	CrCbGaD
Orphenadrine—Methadone—CYP2C19—coronary artery disease	3.58e-05	0.00819	CrCbGaD
Orphenadrine—Promazine—CYP2C19—coronary artery disease	3.2e-05	0.00732	CrCbGaD
Orphenadrine—Trimipramine—HTR2A—coronary artery disease	3.06e-05	0.007	CrCbGaD
Orphenadrine—Promethazine—HTR2A—coronary artery disease	2.95e-05	0.00674	CrCbGaD
Orphenadrine—Doxepin—HTR2A—coronary artery disease	2.92e-05	0.00668	CrCbGaD
Orphenadrine—Imipramine—CYP2C19—coronary artery disease	2.8e-05	0.00641	CrCbGaD
Orphenadrine—Amitriptyline—CYP2C19—coronary artery disease	2.79e-05	0.00637	CrCbGaD
Orphenadrine—Promazine—HTR2A—coronary artery disease	2.6e-05	0.00593	CrCbGaD
Orphenadrine—Imipramine—HTR2A—coronary artery disease	2.27e-05	0.00519	CrCbGaD
Orphenadrine—Amitriptyline—HTR2A—coronary artery disease	2.26e-05	0.00516	CrCbGaD
Orphenadrine—Amitriptyline—ALB—coronary artery disease	1.55e-05	0.00353	CrCbGaD
Orphenadrine—CHRM2—Signaling Pathways—AGTR1—coronary artery disease	4e-06	4.29e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL2—coronary artery disease	3.98e-06	4.27e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6R—coronary artery disease	3.97e-06	4.26e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.97e-06	4.26e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LCAT—coronary artery disease	3.97e-06	4.26e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL10—coronary artery disease	3.97e-06	4.26e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PLG—coronary artery disease	3.96e-06	4.25e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	3.92e-06	4.21e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	3.91e-06	4.19e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	3.91e-06	4.19e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOA4—coronary artery disease	3.9e-06	4.18e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PLG—coronary artery disease	3.89e-06	4.18e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADRB2—coronary artery disease	3.85e-06	4.13e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PRKCE—coronary artery disease	3.8e-06	4.08e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—JAK2—coronary artery disease	3.8e-06	4.08e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SOCS1—coronary artery disease	3.79e-06	4.07e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	3.79e-06	4.07e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTP1—coronary artery disease	3.79e-06	4.06e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—S100B—coronary artery disease	3.79e-06	4.06e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.76e-06	4.04e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GCLM—coronary artery disease	3.76e-06	4.04e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARGC1A—coronary artery disease	3.75e-06	4.02e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SOCS3—coronary artery disease	3.75e-06	4.02e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	3.74e-06	4.02e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	3.74e-06	4.01e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—HMOX1—coronary artery disease	3.73e-06	4.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	3.73e-06	4.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—S100B—coronary artery disease	3.72e-06	4e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTP1—coronary artery disease	3.71e-06	3.98e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KITLG—coronary artery disease	3.7e-06	3.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFBR2—coronary artery disease	3.7e-06	3.97e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	3.69e-06	3.96e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CAT—coronary artery disease	3.68e-06	3.95e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARGC1A—coronary artery disease	3.67e-06	3.94e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—HMOX1—coronary artery disease	3.66e-06	3.92e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.65e-06	3.91e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.65e-06	3.91e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	3.64e-06	3.91e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KITLG—coronary artery disease	3.64e-06	3.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT5A—coronary artery disease	3.62e-06	3.88e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP3—coronary artery disease	3.62e-06	3.88e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CAT—coronary artery disease	3.61e-06	3.87e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.59e-06	3.85e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOB—coronary artery disease	3.58e-06	3.84e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	3.56e-06	3.82e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP3—coronary artery disease	3.56e-06	3.82e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HADH—coronary artery disease	3.54e-06	3.8e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.54e-06	3.8e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOB—coronary artery disease	3.5e-06	3.76e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOB—coronary artery disease	3.5e-06	3.75e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTM1—coronary artery disease	3.48e-06	3.73e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL8—coronary artery disease	3.47e-06	3.72e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—JAK2—coronary artery disease	3.45e-06	3.7e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EDN1—coronary artery disease	3.44e-06	3.69e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOB—coronary artery disease	3.44e-06	3.69e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL5—coronary artery disease	3.42e-06	3.67e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—LPL—coronary artery disease	3.42e-06	3.66e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	3.41e-06	3.66e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTM1—coronary artery disease	3.41e-06	3.66e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	3.4e-06	3.64e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EDN1—coronary artery disease	3.39e-06	3.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CSF2—coronary artery disease	3.37e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGF1—coronary artery disease	3.37e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL5—coronary artery disease	3.36e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOA2—coronary artery disease	3.36e-06	3.6e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.36e-06	3.6e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX2—coronary artery disease	3.36e-06	3.6e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—LPL—coronary artery disease	3.35e-06	3.59e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LPL—coronary artery disease	3.34e-06	3.58e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPX1—coronary artery disease	3.33e-06	3.57e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX4—coronary artery disease	3.31e-06	3.56e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.31e-06	3.56e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HK1—coronary artery disease	3.31e-06	3.56e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.31e-06	3.56e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CSF2—coronary artery disease	3.31e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGF1—coronary artery disease	3.31e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	3.31e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MEF2C—coronary artery disease	3.31e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LPL—coronary artery disease	3.29e-06	3.53e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HADHA—coronary artery disease	3.28e-06	3.51e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPX1—coronary artery disease	3.26e-06	3.5e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	3.26e-06	3.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	3.26e-06	3.49e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CD36—coronary artery disease	3.24e-06	3.48e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.24e-06	3.47e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ITGB3—coronary artery disease	3.23e-06	3.46e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPP2CA—coronary artery disease	3.2e-06	3.44e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LPA—coronary artery disease	3.2e-06	3.43e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CD36—coronary artery disease	3.18e-06	3.41e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	3.17e-06	3.41e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	3.15e-06	3.38e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPP2CA—coronary artery disease	3.14e-06	3.37e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	3.13e-06	3.36e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.1e-06	3.33e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	3.1e-06	3.33e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	3.08e-06	3.31e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PRKCD—coronary artery disease	3.08e-06	3.3e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MTHFR—coronary artery disease	3.07e-06	3.3e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOA5—coronary artery disease	3.07e-06	3.29e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	3.03e-06	3.25e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR2A—coronary artery disease	3.01e-06	3.23e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MTHFR—coronary artery disease	3.01e-06	3.23e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—P4HB—coronary artery disease	3.01e-06	3.23e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—C3—coronary artery disease	3.01e-06	3.23e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	2.96e-06	3.18e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—C3—coronary artery disease	2.96e-06	3.17e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.95e-06	3.17e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AGT—coronary artery disease	2.92e-06	3.13e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HIF1A—coronary artery disease	2.87e-06	3.08e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOE—coronary artery disease	2.86e-06	3.07e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AGT—coronary artery disease	2.86e-06	3.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AGT—coronary artery disease	2.86e-06	3.07e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOA1—coronary artery disease	2.83e-06	3.04e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	2.82e-06	3.03e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AGT—coronary artery disease	2.81e-06	3.02e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOE—coronary artery disease	2.8e-06	3.01e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOE—coronary artery disease	2.8e-06	3e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LEP—coronary artery disease	2.8e-06	3e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—VCAN—coronary artery disease	2.78e-06	2.99e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOA1—coronary artery disease	2.77e-06	2.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOA1—coronary artery disease	2.77e-06	2.97e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.76e-06	2.96e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOE—coronary artery disease	2.76e-06	2.96e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LEP—coronary artery disease	2.76e-06	2.96e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KDR—coronary artery disease	2.74e-06	2.94e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	2.73e-06	2.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	2.72e-06	2.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KDR—coronary artery disease	2.7e-06	2.9e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—DCN—coronary artery disease	2.68e-06	2.88e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	2.68e-06	2.88e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ESR1—coronary artery disease	2.67e-06	2.87e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—F2—coronary artery disease	2.64e-06	2.83e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FN1—coronary artery disease	2.64e-06	2.83e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	2.63e-06	2.82e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	2.63e-06	2.82e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.61e-06	2.8e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	2.61e-06	2.8e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—F2—coronary artery disease	2.6e-06	2.79e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FN1—coronary artery disease	2.6e-06	2.79e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	2.59e-06	2.78e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	2.57e-06	2.75e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LIPC—coronary artery disease	2.54e-06	2.73e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HBA1—coronary artery disease	2.54e-06	2.73e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.54e-06	2.73e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.54e-06	2.73e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOC3—coronary artery disease	2.53e-06	2.71e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KIT—coronary artery disease	2.53e-06	2.71e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LDLR—coronary artery disease	2.51e-06	2.69e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARG—coronary artery disease	2.49e-06	2.67e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KIT—coronary artery disease	2.49e-06	2.67e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.48e-06	2.66e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.48e-06	2.66e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—POMC—coronary artery disease	2.46e-06	2.64e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GCLC—coronary artery disease	2.45e-06	2.63e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CETP—coronary artery disease	2.45e-06	2.63e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARG—coronary artery disease	2.44e-06	2.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SDC1—coronary artery disease	2.43e-06	2.6e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	2.43e-06	2.6e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—POMC—coronary artery disease	2.41e-06	2.58e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CREB1—coronary artery disease	2.41e-06	2.58e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—POMC—coronary artery disease	2.41e-06	2.58e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	2.39e-06	2.56e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—POMC—coronary artery disease	2.37e-06	2.54e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	2.37e-06	2.54e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL2—coronary artery disease	2.35e-06	2.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6R—coronary artery disease	2.35e-06	2.52e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	2.32e-06	2.48e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1—coronary artery disease	2.31e-06	2.48e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	2.31e-06	2.48e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	2.3e-06	2.47e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.29e-06	2.46e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.29e-06	2.46e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	2.28e-06	2.44e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	2.27e-06	2.43e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALB—coronary artery disease	2.24e-06	2.41e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CTGF—coronary artery disease	2.24e-06	2.4e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.22e-06	2.38e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GOT2—coronary artery disease	2.22e-06	2.38e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.2e-06	2.36e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	2.2e-06	2.36e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALB—coronary artery disease	2.2e-06	2.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.17e-06	2.32e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	2.16e-06	2.32e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NOS3—coronary artery disease	2.14e-06	2.3e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGF2—coronary artery disease	2.13e-06	2.28e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NOS3—coronary artery disease	2.1e-06	2.25e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOS3—coronary artery disease	2.1e-06	2.25e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	2.09e-06	2.25e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	2.06e-06	2.21e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.04e-06	2.19e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JAK2—coronary artery disease	2.04e-06	2.19e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	2.01e-06	2.15e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	2e-06	2.14e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.98e-06	2.12e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	1.97e-06	2.11e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—coronary artery disease	1.96e-06	2.1e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—coronary artery disease	1.92e-06	2.06e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GOT1—coronary artery disease	1.92e-06	2.05e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GGT1—coronary artery disease	1.92e-06	2.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.86e-06	2e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	1.83e-06	1.96e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.8e-06	1.93e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.78e-06	1.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.77e-06	1.9e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	1.77e-06	1.9e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	1.75e-06	1.88e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	1.74e-06	1.87e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.73e-06	1.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.72e-06	1.85e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.71e-06	1.83e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.7e-06	1.83e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.7e-06	1.82e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.68e-06	1.81e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CAT—coronary artery disease	1.67e-06	1.8e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.66e-06	1.78e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.63e-06	1.75e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOB—coronary artery disease	1.63e-06	1.74e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.61e-06	1.72e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.58e-06	1.7e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LPL—coronary artery disease	1.55e-06	1.66e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX1—coronary artery disease	1.51e-06	1.62e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.51e-06	1.62e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.49e-06	1.6e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CD36—coronary artery disease	1.47e-06	1.58e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.46e-06	1.56e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.4e-06	1.5e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.39e-06	1.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	1.37e-06	1.46e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.36e-06	1.46e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	1.34e-06	1.44e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AGT—coronary artery disease	1.33e-06	1.42e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOE—coronary artery disease	1.3e-06	1.4e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOA1—coronary artery disease	1.29e-06	1.38e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1.21e-06	1.29e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CA—coronary artery disease	1.18e-06	1.27e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.18e-06	1.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	1.16e-06	1.25e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.13e-06	1.22e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—POMC—coronary artery disease	1.12e-06	1.2e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—coronary artery disease	1.05e-06	1.12e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—coronary artery disease	1.03e-06	1.1e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALB—coronary artery disease	1.02e-06	1.09e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—coronary artery disease	9.86e-07	1.06e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NOS3—coronary artery disease	9.75e-07	1.05e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—coronary artery disease	9.66e-07	1.04e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—coronary artery disease	9.64e-07	1.03e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	9.49e-07	1.02e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—coronary artery disease	8.91e-07	9.56e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.48e-07	5.88e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—coronary artery disease	4.48e-07	4.81e-06	CbGpPWpGaD
